Iovance Biotherapeutics (IOVA) logo

IOVA earnings date, and what happened the last 4 times

Next report

Thu Nov 5

Quality Score today 10

Before the open, in 10 days. Expected: the company has not confirmed it.

IOVA closed higher after 3 of its last 4 reports. On average it closed +22.1% the session after a report.

The moment IOVA reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when IOVA reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after IOVA's last 4 reports

IOVA's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 6, 20262026 · Before open1estimated+37.1%+43.1%
May 7, 20262026 · Before open6estimated-14.2%-13.2%
Feb 24, 20262026 · Before open-1estimated+14.0%+30.8%
Nov 6, 20252025 · Before open-5estimated+24.9%+27.6%
  • Aug 6, 2026, before the open: that session IOVA opened +37.1% and closed +43.1%, and five sessions on it stood +55.3%. Its Quality Score going in was 1 (Below Average), estimated.
  • May 7, 2026, before the open: that session IOVA opened -14.2% and closed -13.2%, and five sessions on it stood -10.5%. Its Quality Score going in was 6 (Average), estimated.
  • Feb 24, 2026, before the open: that session IOVA opened +14.0% and closed +30.8%, and five sessions on it stood +31.1%. Its Quality Score going in was -1 (Poor), estimated.
  • Nov 6, 2025, before the open: that session IOVA opened +24.9% and closed +27.6%, and five sessions on it stood +40.3%. Its Quality Score going in was -5 (Poor), estimated.

Across these 4 reports IOVA opened higher after 3 of 4 and closed higher after 3 of 4; on average it opened +15.4%, closed +22.1%, and stood +29.1% five sessions on. Its Quality Score is 10 today, against 1 going into its Aug 6, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +43.1% after the Aug 6, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see IOVA's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about IOVA's earnings

As of Oct 26, 2026: Iovance Biotherapeutics (IOVA): expected to report Thu Nov 5, before the open. IOVA closed higher after 3 of its last 4 reports. Its Quality Score is 10 (Average). Scores as of 10:16 PM ET, 15 minutes behind.

When is IOVA's next earnings date?

Expected to report Thu Nov 5, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. IOVA closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Does IOVA report before or after the market?

IOVA is expected to report Thu Nov 5, before the open. Its last 4 reports came before the open.

How did IOVA stock react to its last earnings report?

Aug 6, 2026, before the open: that session IOVA opened +37.1% and closed +43.1%, and five sessions on it stood +55.3%.

Does IOVA stock usually go up after earnings?

IOVA closed higher after 3 of its last 4 reports. On average it closed +22.1% the session after a report, after opening +15.4%. Past behavior, not a forecast.

Iovance Biotherapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.